Acquisition of a luminal B- or HER2-enriched profile by luminal/HER2-negative tumors during metastatic progression may be related to tumor evolution or acquisition of estrogen independence (Cejalvo et al., 2017). This evidence concerns the gene ERBB2 and neoplasm.